Methyl 2-(2,5-dioxoimidazolidin-4-yl)acetate, 95.0%, 1g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-((tert-butyldimethylsilyl)oxy)pyrrolidine-2-carboxylic acid, 97%, 1g

6-Bromo-2-hydroxyquinoxaline, 95.0%, 250mg

2,4-Dichloro-5-(trifluoromethoxy)aniline, 95.0%, 25g

2-AMINO-5-METHOXY-4-METHYLBENZOIC ACID, 95.0%, 1g

Ethyl 3-amino-5-methyl-1H-pyrrole-2-carboxylate, 250mg

(S,R)-BdtbIn-Sabox, 97%, 250mg

3,5-Dibromo-4-nitro-1H-pyrazole, 97.0%, 5g

3-Trifluoromethylpyrrolo[2,3-b]pyridine, 97.0%, 10g

(5-(Trifluoromethyl)-2-(2-(trifluoromethyl)pyrimidin-5-yl)pyridin-4-yl)methanamine, 98%, 100mg

4,5,6,7-TETRABROMO-1H-BENZOTRIAZOLE, 97%, 10mg

2-Acetamido-5-nitropyridine>98.0%(GC)1g

GC capillary column ROTI®Cap-5, 30 m, 0.53 mm, 1.00 µm, 1 Piece(s)